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Abstract
Introduction and hypothesis The objective of this study
was to assess the effect of the tension-free vaginal mesh
(Prolift™) procedure on the non-treated and initially
unaffected vaginal compartments.
Methods This prospective observational cohort study in-
volved 150 patients who underwent a Prolift™ procedure.
Pelvic organ prolapse (POP) quantification and evaluation
of prolapse symptoms with validated questionnaires was
performed pre-operatively and 6 and 12 months postoper-
atively. Primary outcome was the rate of POP stage ≥II in
the non-treated vaginal compartments.
Results Twenty-three percent of all patients developed a de
novo POP stage ≥II in the untreated compartment. This
occurred in 46% and 25% of patients after an isolated
anterior and isolated posterior Prolift™, respectively.
Conclusion Tension-free vaginal mesh treatment of one
vaginal compartment seems to provoke the development of
vaginal prolapse in initially unaffected vaginal compartments,
particularly after an isolated anterior Prolift™ procedure.
Keywords Prolift™.Pelvicorganprolapse.
Unaffectedvaginalcompartment.Mesh.Trocar-guided.
Tension-free
Abbreviations
POP pelvic organ prolapse
POP-Q pelvic organ prolapse quantification system
ICS International Continence Society
UDI Urogenital Distress Inventory
Introduction
Pelvic organ prolapse (POP) has a high prevalence in
parous women [1]. A wide variety of abdominal and
vaginal surgical techniques is available for the treatment
of POP, indicating lack of consensus on the optimal
treatment. The choice of the type of operation depends on
multiple factors such as site and severity of prolapse,
additional symptoms, and the surgeon’s preference and
capability. In order to prevent recurrence, the use of
synthetic meshes and biological grafts in pelvic reconstruc-
tive surgery has increased considerably in recent years. The
results of prolapse repair with synthetic mesh are promis-
ing, with success rates ranging from 71-100% [2]. Mesh
exposure, infection, dyspareunia, constipation, urgency,
urge urinary incontinence, and urinary retention are
reported as adverse effects, as well as bladder and rectal
injury and bleeding during surgery.
Since 2005, we performed an ongoing prospective
observational cohort study to evaluate the anatomical and
functional efficacy as well as morbidity of POP repair with
a tension-free Vaginal Mesh Kit (Prolift™ Ethicon, Somer-
ville, NJ, USA). During the systematic follow-up of these
patients, the clinical impression rose that mesh treatment of
one vaginal compartment provoked the development of
vaginal prolapse in other initially unaffected compartments.
In a previous study, Raalte et al. reported prolapse in the
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15.5% of cases [3]. In contrast, only 5.3% of patients who
underwent conventional prolapse surgery without mesh
needed repeat prolapse surgery within 5 years in the
compartment that previously appeared well-supported [4].
The aim of this article, therefore, is to evaluate the
anatomical effect of Prolift™ treatment and its impact on
prolapse symptoms on the non-treated and initially unaf-
fected vaginal compartments.
Material and methods
In two Dutch centers (Radboud University Nijmegen Medical
Centre and Reinier de Graaf Group Delft) specializing in
pelvic organ dysfunction and surgery, prolapse repair with the
Prolift™ system was performed since September 2005. After
obtained informed consent, consecutive patients with a
recurrent POP stage ≥II and those with a primary POP stage
≥III were enrolled in this prospective observational cohort
study. Surgery was performed by four gynecologists who
were trained for the Prolift™ procedure as described in the
paper by Fatton et al. prior to enrolment of patients in this
study [5]. As recommended by these authors, a midline
incision was made which included full thickness of the
fibromuscular wall of the vagina. The vagina was closed
without resection of any vaginal tissue with a continuous
running Vicryl 2.0 suture. No simultaneous hysterectomy or
T-incisions were made in order to reduce the chance of mesh
exposure and erosions [5].
POP was quantified pre-operatively and during follow-
up at 6 and 12 months postoperatively according to the
pelvic organ prolapse quantification (POP-Q) system, as
recommended by the International Continence Society [6].
Subjective symptoms were obtained pre-operatively and
during follow-up visits at 6 and 12 months postoperatively
with the standard urogynecological questionnaire of the
Dutch Pelvic Floor Society (a disease-specific quality of
life questionnaire which among others contains the Uro-
genital Distress Inventory (UDI). The questionnaire as a
whole has been validated for the Dutch language [7]. Since
the aim of this study was to specifically evaluate the
anatomic effect of Prolift™ treatment on the non-treated
and initially unaffected vaginal compartments, we only
used the domain score on genital prolapse of the UDI. We
choose to include only this domain since vaginal bulging
symptoms are the only symptoms that are consistently
associated with vaginal prolapse [8].
PrimaryoutcomeofthisstudywastherateofPOPstage≥II
in the non-treated and initially unaffected compartments.
Secondary outcomes were UDI scores on the domain of
genital prolapse, anatomical success in the mesh-treated
compartments, defined as POP stage≤I, as well as morbidity.
Data on patient and surgical characteristics are presented
as numbers with corresponding percentages or medians
with range. Comparison between proportions was per-
formed using the Pearson’s chi-square test. Mean domain
scores and standard deviations were calculated on the UDI
domain genital prolapse. Differences in means between
baseline and 12-month follow-up were tested with the
paired sample t test and differences in means between
different groups were tested with the independent sample t
test. Data were analyzed with the Statistical Package for the
Social Sciences, version 16.0. A p value of <0.05 was
considered significant.
Results
Since the start of our study, 297 patients underwent the
Prolift™ procedure and were registered in our database. On
January 1, 2009, 196 patients had completed a follow-up of
at least 12 months. Patients with a total Prolift™ procedure
(46 patients) for post-hysterectomy vaginal vault prolapse,
in whom, by definition, all three compartments are restored,
were excluded from this study, leaving 150 patients for
analysis. At baseline, POPQ data of 147 patients were
complete and these patients were eligible for anatomic
analysis. Two patients could not visit the hospital for the
12-month follow-up, leaving 145 patients for follow-up
analysis. At follow-up, 127 patients (88%) had completed
the validated questionnaire.
Patient and surgical characteristics are presented in
Table 1. Median age was 64 years (range 32–89). In those
patients who underwent a primary repair, median age was
71 years (range 55–89). Ninety-five patients (63%) under-
went prior POP surgery, 28 (19%) of those underwent more
than one prior prolapse repair. Thirty-five patients (23%)
underwent an anterior Prolift™ repair, 80 (54%) a posterior
Prolift™ repair, and 35 (23%) a combined anterior and
posterior Prolift ™ repair. Three (2%) bladder perforations
occurred, all during dissection for an anterior Prolift™
procedure. In two of these patients, the anterior mesh was
not placed, but the procedure was converted into a
conventional anterior colporrhaphy. One superficial serosa
lesion of the rectum occurred, without a perforation. The
mesh procedure was continued, since the rectum wall was
intact. One patient (1%) had significant hemorrhage
(>500 ml) and five patients (3%) developed a postoperative
hematoma. Ten patients (7%) had temporary postoperative
urinary retention, which resolved spontaneously in all cases
within 11 days. In 15 patients (10%), a mesh exposure was
detected, six cases at the 6-month follow-up visit and nine
at the 12-month follow-up visit. Most of these patients were
asymptomatic. Only one patient complained of pain and
one other of de novo dyspareunia, but none of them had
272 Int Urogynecol J (2010) 21:271–278vaginal discharge or signs of infection. The size of these
mesh exposures varied from 2 to 20 mm. All mesh
exposures were easily excised and covered with vaginal
mucosa in a minor day-care procedure after initial treatment
with local estrogens.
POP stages per compartment are shown in Table 2,
divided into three categories: those who underwent a
solitary anterior Prolift™, a solitary posterior Prolift™,o r
a combined anterior and posterior Prolift™ procedure. In
Table 2, the patients who underwent concomitant, non-
mesh surgery are included. Patients who underwent repeat
surgery before 12 months follow-up were considered
failures.
In Table 3, the effect on the non-operated compartment
is shown in patients without concomitant surgery. UDI
scores on the domain of genital prolapse are shown in
Table 4.
Results after anterior Prolift™
Anatomical success at 1 year in the anterior compartment
after anterior Prolift™ repair was 89% (Table 2). Sixteen
patients (46%) had a post-operative POP stage II or III of
the posterior compartment, of whom three patients had
already undergone repeat surgery with a posterior Prolift™
before the 12 months follow-up visit, resulting in a 54%
"success" rate. In Table 3, deterioration and improvement of
the posterior vaginal wall (Bp) is shown. Twenty-six
patients underwent an anterior Prolift™ without concomi-
tant posterior colporrhaphy or sacrospinous fixation. In
three patients (12%), point Bp improved with 1 cm.
However, in 16 patients (62%), the posterior wall deterio-
rated (1-4 cm) and in 12 patients (46%), a de novo POP
stage ≥II of the posterior compartment was diagnosed at the
12-month follow-up visit.
Table 1 Patient and surgical characteristics
Anterior prolift
(n=35)
Posterior prolift
(n=80)
Anterior+posterior prolift
(n=35)
All patients
(n=150)
Age
a 64 (34–82) 60 (35–87) 68 (32–89) 64 (32–89)
Parity
a 2( 1 –5) 2 (0–6) 3 (1–7) 2 (0–7)
BMI
a 26 (21–31) 25 (20–36) 26 (20–37) 26 (20–37)
Previous prolapse surgery
b 24 (69%) 61(76%) 10 (39%) 95 (63%)
Operating time (min)
a 50 (32–120) 45 (29–135) 80 (40–150) 50 (29–150)
Bloodloss (ml)
a 100 (50–300) 100 (50–300) 125 (50–1200) 100 (50–1200)
Concomitant surgery
b 12 (34%) 15 (19%) 4(11%) 32 (21%)
Anterior colporraphy 0 8 0 8
Posterior colporraphy 7 0 0 7
Perineorrhaphy 3 2 3 8
Cervical amputation 0 0 1 1
Enterocele repair 0 3 0 3
Monarc/tvt/tvt-o 0 2 1 3
Sacrospinous fixation 2 0 0 2
Analgesia
Spinal
b 19 (54%) 37 (46%) 16 (46%) 72 (48%)
General
b 13 (37%) 34 (43%) 13 (37%) 60 (40%)
Duration urinary catheter (days)
a 2( 1 –11) 1 (1–10) 2(2–6) 2 (1–11)
Hospital stay (days)
a 4( 2 –11) 4 (2–6) 4 (3–11) 4 (2–11)
Complications
Bladder perforation
b 3 (8%) 0 0 3 (2%)
Rectum serosalesion
b 0 1 (1%) 0 1 (1%)
Hemorrhage >500 ml
b 0 0 1 (3%) 1 (1%)
Repeat surgery for postoperative hemorrhage
b 0 1 (1%) 1 (3%) 2 (1%)
Hematoma
b 2 (6%) 1 (1%) 0 3 (2%)
Urinary retention
b 5 (14%) 3 (4%) 2 (6%) 10 (7%)
Mesh exposure
b 2 (6%) 9 (11%) 4 (11%) 15 (10%)
amedian (range)
bnumber of patients (%)
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274 Int Urogynecol J (2010) 21:271–278Five patients (14%) had a post-operative POP stage II or
III of the apical compartment resulting in 86% "success"
rate (Table 2). In Table 3, it is demonstrated that in five
patients (19%) the apical compartment deteriorated, and in
three patients (12%) a de novo POP stage ≥II of the apical
compartment was detected. These three patients also
developed a de novo prolapse in the posterior compartment.
Pre-operatively, there was one patient with an apical
compartment POP stage III. Due to scar tissue, it was not
possible to perform any other surgery then an isolated
anterior Prolift™. At 12 months, the apical compartment of
this patient was classified as POP stage II. In two patients, a
pre-operative POP stage II of the apical compartment
resolved without concomitant intervention.
In conclusion, of the 26 patients who underwent an
anterior Prolift™ without concomitant surgery, 12 (46%)
developed a de novo POP stage ≥II in the non-mesh, non-
treated compartment.
Genital prolapse symptoms were evaluated with UDI
domain genital prolapse (Table 4). In all patients that
underwent an anterior Prolift™, this score improved signif-
icantly. However, patients that developed de novo prolapse
had a significantly higher bother score at 12 months as
compared to patients without de novo prolapse.
Table 3 Effect on non-treated compartment at 12 months
Anterior Prolift™
(n=26)
Posterior Prolift™
(n=65)
Anterior+posterior Prolift™
(n=33)
All patients
(n=124)
Ba improvement 13 (20%)
Ba equal 30 (46%)
Ba deterioration 22 (34%)
De novo stage ≥II anterior compartment 16 (25%)
C improvement 18 (69%) 45 (69%) 31(94%)
C equal 3 (12%) 11 (17%) 0
C deterioration 5 (19%) 9 (14%) 2 (6%)
De novo stage ≥II apical compartment 3 (12%) 2 (3%) 0
Bp improvement 3 (12%)
Bp equal 7 (27%)
Bp deterioration 16 (62%)
De novo stage ≥II posterior compartment 12 (46%)
De novo stage ≥II non-mesh compartment 12 (46%)
* 16 (25%)* 0 28 (23%)
Ba most descendant point at anterior vaginal wall, C cervix or vaginal apex, Bp most descendant point at posterior vaginal wall
*p=0.04, chi-square test
Baseline 12months p value
All prolift™ procedures
All patients (n=127) 57.8 (32.7) 9.4 (21.2) <0.001
Patients without concomitant surgery (n=114) 57.7 (33.4) 9.4 (21.3) <0.001
Without de novo prolapse (n=86) 58.1 (33.8) 4.2 (14.5)* <0.001
With de novo prolapse (n=28) 56.8 (33.7) 23.2 (31.9)* <0.001
Anterior Prolift™
Patients without concomitant surgery (n=23) 58.7 (31.0) 18.1 (31.3) <0.001
Without de novo prolapse (n=11) 55.6 (36.3) 0 (0)
** <0.001
With de novo prolapse (n=12) 61.1 (27.8) 32.1 (36.3)
** 0.019
Posterior Prolift™
Patients without concomitant surgery (n=59) 56.3 (34.9) 7.3 (18.4) <0.001
Without de novo prolapse (n=43) 57.1 (34.4) 4.9 (14.6)
*** <0.001
With de novo prolapse (n=16) 53.3 (38.4) 15.6 (26.3)
*** 0.001
Anterior+posterior Prolift™
Patients without concomitant surgery (n=32) 59.4 (33.0) 7.1 (16.2) <0.001
With adequate improvement (n=24) 52.8 (35.2) 4.2 (4.1)
**** <0.001
Without adequate improvement (n=8) 53.7 (28.8) 16.6 (19.9)
**** 0.013
Table 4 UDI domain score
genital prolapse at baseline and
12 months
Scores range between 0 (least
bother)to100(maximumbother).
Data presented as means
(±standard deviation)
*p<0.001, independent sample
t test
**p=0.01, independent sample
t test
***p=0.06, independent sample
t test
****p=0.06, independent
sample t test
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Anatomical success in the posterior compartment in
patients who underwent an isolated posterior Prolift™ was
90% at 12 months (Table 2). Thirty-one patients (40%) had
ap o s t - o p e r a t i v eP O Ps t a g eI Io rI I Ii nt h ea n t e r i o r
compartment, of whom one patient was treated with an
anterior Prolift™ before the 12-months follow-up visit
resulting in a 60% "success" rate.
In Table 3, deterioration and improvement of the anterior
vaginal wall (Ba) is shown after a posterior Prolift™. Sixty-
five patients underwent no concomitant surgery. Deteriora-
tion occurred in 35% of them. In 16 patients (25%), a de
novo POP stage II or III of the anterior compartment was
diagnosed at 12 months.
Five patients (8%) had a POP stage ≥II of the apical
compartment at 12 months. In only two patients (3%), this
was a de novo apical prolapse. These two patients were also
diagnosed with a de novo anterior compartment prolapse.
In conclusion, of the 65 patients with a posterior
Prolift™ without concomitant surgery, 16 (25%) developed
a de novo POP stage ≥II in the non-mesh, non-treated
compartment.
Inall,patientsthatunderwentaposteriorProlift™,th eU DI
score on the domain genital prolapse improved significantly
(Table4). Patients that developed de novo prolapse showed a
higher bother score at 12 months as compared to patients
without de novo prolapse. The difference, however, was not
statistically significant (p=0.06).
De novo POP after an isolated posterior Prolift™ was
diagnosed less often compared to de novo POP after an
isolated anterior Prolift™ (25% vs. 46%) (p=0.044).
Results after a combined anterior and posterior Prolift™
Anatomical success at 12 months in patients with a
combined anterior and posterior Prolift™ procedure was
79% for the anterior compartment, 91% for the posterior
compartment, and 76% for the apical compartment
(Table 2). In Table 3, deterioration and improvement of the
apical compartment is shown. In only two patients (6%), a
deterioration of the apical compartment was detected, though
these patients were still classified as having POP stage I,
which, by definition, is not regarded as a failure. Despite an
improvement in centimeters compared to baseline, however,
eight patients (24%) were still diagnosed with POP stage ≥II
of the apical compartment, of which two had additional
surgery within 1 year; one laparoscopic cervicosacropexy,
and one vaginal hysterectomy with a high Mc Call
procedure. In all these eight patients, it was the uterus that
had descended, not a vaginal vault.
In conclusion, none of the 35 patients with a combined
anterior and posterior Prolift™ developed a de novo
prolapse. However, in eight patients (24%), the improve-
ment of the apical compartment prolapse was insufficient.
In all patients that underwent an anterior+posterior
Prolift™, the UDI score on the domain genital prolapse
improved significantly (Table 4). Patients who were still
diagnosed with POP ≥II showed a higher bother score as
compared to patients with a POP <II. The difference,
however, was not statistically significant (p=0.06).
In summary, 28 patients (23%) who underwent a
Prolift™ procedure (anterior, posterior or combined) were
diagnosed with de novo POP stage ≥II in the untreated
compartment, and they all had higher bother scores on the
UDI domain genital prolapse compared to patients without
de novo prolapse. Six patients (4%) had to undergo repeat
surgery in the previously non-mesh-treated compartment
within the first year of follow-up.
Discussion
The symptomatic de novo POP rate in the non-mesh-treated
compartment appeared to be alarmingly high, particularly
after an isolated anterior Prolift™. Our de novo POP rate in
the non-treated compartment (23%) appeared higher than
previously reported by Raalte et al. (15.5%) [3]. One
explanation for this difference could be that our study
population consisted of a higher number of patients with
prior prolapse surgery compared to the population described
by Raalte et al. (63% vs. 45%) [3]. The study of Clark et al.
on conventional vaginal prolapse surgery demonstrated a
repeat surgery rate in the untreated compartment in only
5.3% of patients after 5 years, whereas in our study, this rate
was already 4% within the first year [4].
De novo POP in the non-mesh-treated compartment was
diagnosedlesscommonafteraposteriorProlift™thanafteran
anterior Prolift™ (25% vs. 46%). Previous studies demon-
strated that restoration of DeLancey’sl e v e lIs u p p o r t
diminishes the rate of anterior and posterior wall prolapse [9,
10]. The position of the arms of the posterior Prolift™
through the sacrospinous ligaments ensures level I support,
which potentially results in less de novo POP after a
posterior Prolift™ compared to an anterior Prolift™.A
recent study, using three-dimensional models generated from
magnetic resonance pelvic imaging in women with normal
pelvic support, demonstrated that an anterior mesh mainly
offers level II support and not enough level I support, since
the upper part of the vagina lies well above and posterior
to the distal suspension points of the anterior mesh [11].
Since the posterior Prolift™ procedure does provide ade-
quate level I support and the anterior Prolift™ mainly
provides level II support, this could explain why we detected
an almost twofold higher de novo POP rate after an isolated
anterior compared to an isolated posterior Prolift™.
276 Int Urogynecol J (2010) 21:271–278We found no de novo POP in the apical compartment
after a combined anterior and posterior Prolift™.H o w e v -
er, if the uterus was left in situ, the improvement of the
apical compartment was still insufficient (POP stage II or
III) in eight cases (24%). Our previously published results,
after a total Prolift™ procedure with one continuous mesh
for post-hysterectomy vaginal vault prolapse, were signif-
icantly better (failure rate 9%) [12]. In order to prevent
possible descent of the uterus, the French Tension-free
Vaginal Mesh group advised us, during the study, to
remove a little part of the mesh at the level where this is
fixated to the uterus to ensure a more adequate and, thus,
higher suspension of the uterus.
Inthemesh-treatedcompartments,thesuccessratesof89%
(95% CI 78–99) after an anterior mesh and 90% (95% CI 83–
97) after a posterior mesh were comparable with other reports
on Prolift™ with 1 year follow-up [3, 13]. In the present
study, the number of complications was comparable as well
with previous reports [3, 5, 13]. Although Raalte et al.
reported no patients with mesh exposure, our incidence of
mesh exposure (10%) was comparable with an exposure rate
of 11% described by Elmer [3, 13]. Despite the fact that
mesh exposures rarely caused severe complaints and could
be easily excised and covered with vaginal mucosa, it
remains an important concern for the future, since the
follow-up in this study of 1 year is still relatively short,
and the exposure rate might still rise.
The high success rates in the mesh-treated compartments
and the high rates of (de novo) symptomatic prolapse in the
unaffected/untreated compartments could indicate that we
have to change our surgical strategies. Urogynecologists
have to realize that placing a mesh in one compartment can
provoke or deteriorate a prolapse in any other compartment.
It seems logical to be "more liberal" in using mesh, also, in
none or minor affected compartments. Whether such a
strategy will improve results without an increase in
morbidity, such as mesh exposure, mesh retraction and
dyspareunia remains to be seen. Providing adequate level I
support without the use of more mesh is another surgical
strategy, for example adding a sacrospinous hysteropexy or
a sacrospinous fixation as a preventive measure of de novo
POP to an anterior Prolift™ procedure. Other effective
surgical alternatives are the modified Manchester procedure
or vaginal hysterectomy with high Mc Call procedure to
restore or prevent apical compartment prolapse and, thus,
ensuring adequate level I support [14].
In our opinion, the strengths of this study are the high
number of patients with adequate follow-up of 12 months,
the prospective data collection, and the use of validated
instruments of measurement, such as POP-Q and urogyne-
cological questionnaires. A relative drawback is the lack of
a control group. A control group with conventional non-
mesh surgery might answer the question whether prolapse
in the previously unaffected compartments is more often
provoked by mesh surgery than by conventional surgery.
Conclusion
Our data suggest that mesh treatment of only one vaginal
compartment does provoke the development of POP in
other initially unaffected compartments. The development
of de novo POP stage ≥II in previously unaffected
compartments is almost twice as high after an isolated
anterior Prolift™ than after an isolated posterior Prolift™.
In case of a POP stage ≥II of the anterior compartment and
a stage I of the posterior and/or apical compartment, we
suggest to add level I support by a conventional sacrospi-
nous hysteropexy. If there is no uterus in situ, we would
suggest considering a total Prolift™ procedure since the
results of this treatment are highly effective as reported
earlier by us [12]. We feel that patients should be counseled
about this strategy and about the pros and cons of
additional mesh surgery. They should also be made aware
of the potential risk on secondary surgery if no additional
treatment is performed initially.
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